What should I Know Regarding Pregnancy, Nursing and Administering Filgrastim-Aafi 480 Mcg/0.8 Ml Subcutaneous Syringe to Children or the Elderly?
If you are PREGNANT
- Requires a Risk/Benefit Assessment:
If you are NURSING
- Precaution: POOR ORAL BIOAVAILABILITY
If you are an adult over 60
Giving Filgrastim-Aafi 480 Mcg/0.8 Ml Subcutaneous Syringe to a child under 12
- Management or Monitoring Precaution: Rare reports of development of MDS and AML with underlying congenital neutropenia and chronic use. Rare postmarketing reports of decreased bone density with extended use.
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.